In addition, the expression of Bcl-2 was associated with the adverse outcome of RCC with sarcomatoid differentiation and Bcl-2 could be an important prognostic factor for the overall survival in RCC with sarcomatoid differentiation. The gene discussed is BCL2; the disease is renal cell carcinoma.